Birdwatch Note
2024-02-21 15:56:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Homöopathie hat über den Placebo-Effekt hinaus keine nachweisbare Wirkung: https://www.br.de/nachrichten/wissen/homoeopathie-wirkung-bei-keiner-krankheit-mehr-als-placebo,U19Qmls Die im Post verlinkte Quelle beruft sich aber auf eine Studie, deren Autoren Finanzierung von Herstellern anthroposophischer und homöopathischer Produkte erhielten: https://pubmed.ncbi.nlm.nih.gov/37805577/
Written by A607CC7BE8CE91991C7D39059B617A5C92280C91BE7587C21C2E2B8C705CDB52
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1759834224385728843
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1760332600726401166
- noteId - 1760332600726401166
- participantId -
- noteAuthorParticipantId - A607CC7BE8CE91991C7D39059B617A5C92280C91BE7587C21C2E2B8C705CDB52 Participant Details
- createdAtMillis - 1708530972067
- tweetId - 1759834224385728843
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Homöopathie hat über den Placebo-Effekt hinaus keine nachweisbare Wirkung: https://www.br.de/nachrichten/wissen/homoeopathie-wirkung-bei-keiner-krankheit-mehr-als-placebo,U19Qmls Die im Post verlinkte Quelle beruft sich aber auf eine Studie, deren Autoren Finanzierung von Herstellern anthroposophischer und homöopathischer Produkte erhielten: https://pubmed.ncbi.nlm.nih.gov/37805577/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-02-21 15:56:12 UTC (1708530972067) |
2024-02-21 19:15:37 UTC (1708542937020) |
CURRENTLY_RATED_HELPFUL | 2024-02-22 02:02:41 UTC (1708567361294) |
CURRENTLY_RATED_HELPFUL | 2024-02-21 19:15:37 UTC (1708542937020) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-02-21 17:10:59 -0600 | Rating Details | |
| 2024-02-21 16:38:29 -0600 | Rating Details | |
| 2024-02-21 15:26:45 -0600 | Rating Details | |
| 2024-02-21 15:12:15 -0600 | Rating Details | |
| 2024-02-21 14:19:43 -0600 | Rating Details | |
| 2024-02-21 14:09:26 -0600 | Rating Details | |
| 2024-02-21 13:18:55 -0600 | Rating Details | |
| 2024-02-21 12:55:47 -0600 | Rating Details | |
| 2024-02-21 12:29:53 -0600 | Rating Details | |
| 2024-02-21 12:24:39 -0600 | Rating Details | |
| 2024-02-21 12:14:16 -0600 | Rating Details | |
| 2024-02-21 12:10:40 -0600 | Rating Details | |
| 2024-02-21 11:12:43 -0600 | Rating Details | |
| 2024-02-21 11:08:11 -0600 | Rating Details | |
| 2024-02-22 12:08:12 -0600 | Rating Details | |
| 2024-02-22 11:07:37 -0600 | Rating Details | |
| 2024-02-22 05:58:24 -0600 | Rating Details | |
| 2024-02-22 03:56:29 -0600 | Rating Details | |
| 2024-02-22 03:10:02 -0600 | Rating Details | |
| 2024-02-22 02:59:10 -0600 | Rating Details | |
| 2024-02-22 01:13:26 -0600 | Rating Details | |
| 2024-02-22 01:12:43 -0600 | Rating Details | |
| 2024-02-22 01:02:17 -0600 | Rating Details | |
| 2024-02-21 19:37:20 -0600 | Rating Details | |
| 2024-02-23 06:30:38 -0600 | Rating Details | |
| 2024-02-22 09:40:04 -0600 | Rating Details | |
| 2024-02-22 09:10:31 -0600 | Rating Details | |
| 2024-02-22 07:07:17 -0600 | Rating Details | |
| 2024-02-22 06:17:02 -0600 | Rating Details | |
| 2024-02-22 05:03:42 -0600 | Rating Details | |
| 2024-02-22 04:36:57 -0600 | Rating Details | |
| 2024-02-22 01:47:37 -0600 | Rating Details | |
| 2024-02-22 01:37:23 -0600 | Rating Details | |
| 2024-02-22 00:08:29 -0600 | Rating Details | |
| 2024-02-22 00:00:48 -0600 | Rating Details | |
| 2024-02-21 23:57:01 -0600 | Rating Details | |
| 2024-02-21 19:52:53 -0600 | Rating Details | |
| 2024-02-21 17:01:19 -0600 | Rating Details | |
| 2024-02-21 16:57:51 -0600 | Rating Details | |
| 2024-02-21 16:57:38 -0600 | Rating Details | |
| 2024-02-21 16:31:27 -0600 | Rating Details | |
| 2024-02-21 15:52:10 -0600 | Rating Details | |
| 2024-02-21 14:13:58 -0600 | Rating Details | |
| 2024-02-21 13:53:41 -0600 | Rating Details | |
| 2024-02-21 13:41:05 -0600 | Rating Details | |
| 2024-02-21 12:41:14 -0600 | Rating Details | |
| 2024-02-21 12:08:52 -0600 | Rating Details | |
| 2024-02-21 11:40:51 -0600 | Rating Details | |
| 2024-02-21 11:29:13 -0600 | Rating Details | |
| 2024-02-21 10:49:06 -0600 | Rating Details | |
| 2024-02-21 10:25:15 -0600 | Rating Details | |
| 2024-02-21 10:12:48 -0600 | Rating Details | |
| 2024-02-23 03:20:22 -0600 | Rating Details | |
| 2024-02-22 08:29:07 -0600 | Rating Details | |
| 2024-02-22 08:19:33 -0600 | Rating Details | |
| 2024-02-22 03:29:41 -0600 | Rating Details | |
| 2024-02-22 01:26:44 -0600 | Rating Details | |
| 2024-02-21 23:27:46 -0600 | Rating Details | |
| 2024-02-21 21:57:48 -0600 | Rating Details | |
| 2024-02-21 19:06:28 -0600 | Rating Details | |
| 2024-02-21 18:15:37 -0600 | Rating Details | |
| 2024-02-21 18:03:49 -0600 | Rating Details | |
| 2024-02-21 17:04:23 -0600 | Rating Details | |
| 2024-02-21 17:02:05 -0600 | Rating Details | |
| 2024-02-21 15:20:56 -0600 | Rating Details | |
| 2024-02-21 15:05:46 -0600 | Rating Details | |
| 2024-02-21 14:30:47 -0600 | Rating Details | |
| 2024-02-21 13:53:49 -0600 | Rating Details | |
| 2024-02-21 12:44:48 -0600 | Rating Details | |
| 2024-02-21 12:43:32 -0600 | Rating Details | |
| 2024-02-21 12:26:49 -0600 | Rating Details | |
| 2024-02-21 12:23:13 -0600 | Rating Details | |
| 2024-02-21 12:17:14 -0600 | Rating Details | |
| 2024-02-21 12:13:50 -0600 | Rating Details | |
| 2024-02-21 12:10:15 -0600 | Rating Details | |
| 2024-02-21 12:02:06 -0600 | Rating Details | |
| 2024-02-21 11:09:06 -0600 | Rating Details | |
| 2024-02-21 10:38:11 -0600 | Rating Details | |
| 2024-02-21 10:04:31 -0600 | Rating Details | |
| 2024-02-29 03:11:54 -0600 | Rating Details | |
| 2024-02-21 17:52:43 -0600 | Rating Details |